Recent Finacing
Recent Raise
Pamlico BioPharma is a research-stage biopharma developing fully human monoclonal antibody therapeutics and point-of-care diagnostics, including PneumomAb™ (multiserotype anti–Streptococcus pneumoniae) in preclinical development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors